249 related articles for article (PubMed ID: 35454086)
1. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B
Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
[TBL] [Abstract][Full Text] [Related]
3. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective activity of ursodeoxycholic acid in CHMP2B
West RJH; Ugbode C; Fort-Aznar L; Sweeney ST
Neurobiol Dis; 2020 Oct; 144():105047. PubMed ID: 32801000
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis.
Ugbode C; West RJH
Neurobiol Dis; 2021 Jan; 147():105144. PubMed ID: 33144171
[TBL] [Abstract][Full Text] [Related]
6. The role of CHMP2B
Krasniak CS; Ahmad ST
Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
[TBL] [Abstract][Full Text] [Related]
7. Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia.
West RJ; Lu Y; Marie B; Gao FB; Sweeney ST
J Cell Biol; 2015 Mar; 208(7):931-47. PubMed ID: 25800055
[TBL] [Abstract][Full Text] [Related]
8. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
[TBL] [Abstract][Full Text] [Related]
9. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia.
Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S
J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215
[TBL] [Abstract][Full Text] [Related]
10. Expression of mutant CHMP2B linked to neurodegeneration in humans disrupts circadian rhythms in
Lee D; Zheng X; Shigemori K; Krasniak C; Bin Liu J; Tang C; Kavaler J; Ahmad ST
FASEB Bioadv; 2019 Aug; 1(8):511-520. PubMed ID: 32123847
[TBL] [Abstract][Full Text] [Related]
11. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
Cheruiyot A; Lee JA; Gao FB; Ahmad ST
FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
[TBL] [Abstract][Full Text] [Related]
12. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
[TBL] [Abstract][Full Text] [Related]
13. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
[TBL] [Abstract][Full Text] [Related]
15. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
[TBL] [Abstract][Full Text] [Related]
16. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias.
Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB
Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997
[TBL] [Abstract][Full Text] [Related]
17. Expression of a human variant of CHMP2B linked to neurodegeneration in Drosophila external sensory organs leads to cell fate transformations associated with increased Notch activity.
Wilson C; Kavaler J; Ahmad ST
Dev Neurobiol; 2020 Mar; 80(3-4):85-97. PubMed ID: 31587468
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus reactivation in CHMP2BIntron5 models of frontotemporal dementia.
Fort-Aznar L; Ugbode C; Sweeney ST
Hum Mol Genet; 2020 Sep; 29(16):2637-2646. PubMed ID: 32628265
[TBL] [Abstract][Full Text] [Related]
19. Molecular Genetics of Frontotemporal Dementia Elucidated by
Vandal SE; Zheng X; Ahmad ST
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890743
[TBL] [Abstract][Full Text] [Related]
20. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
